News
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...
1d
Medpage Today on MSNThe Future of ART Regimens for HIV Is in Long-Acting Agents
Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...
The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...
A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing continues. Positively UK, ...
With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...
A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...
Receiving treatment within the first month of life could protect children for at least three years, a study suggests.
Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...
1d
News-Medical.Net on MSNHIV trial points to semaglutide as a new anti-aging contender
Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by ...
Lori Cannon, a renowned Chicago activist and advocate for Chicago's LGBTQ+ community and people living with HIV/AIDS, died ...
While federal sexual wellness research funding is cut, Dallas County continues to report high rates of preventable diseases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results